Viking Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Viking Therapeutics is scheduled to report earnings on July 24, 2024, and the estimated EPS forecast is €-0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -27.36M	$ 4.48M	$ -22.53M	$ -19.23M	$ -19.53M
EBITDA	$ -30.07M	$ 33.57M	-	$ -19.12M	$ -19.43M
Net Income Common Stockholders	$ -27.36M	$ -24.61M	$ -22.53M	$ -19.23M	$ -19.53M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 962.98M	$ 362.08M	$ 376.24M	$ 392.92M	$ 135.66M
Total Assets	$ 967.52M	$ 368.49M	$ 382.66M	$ 400.69M	$ 150.90M
Total Debt	$ 1.18M	$ 1.26M	$ 1.34M	$ 1.41M	$ 1.49M
Net Debt	$ -961.79M	$ -360.82M	$ -374.90M	$ -391.51M	$ -134.17M
Total Liabilities	$ 33.63M	$ 20.07M	$ 14.42M	$ 14.58M	$ 16.83M
Stockholders Equity	$ 933.89M	$ 348.42M	$ 368.24M	$ 386.12M	$ 134.06M
Cash Flow	-
Free Cash Flow	$ -6.13M	$ -17.64M	-	$ -11.44M	$ -24.64M
Operating Cash Flow	$ -6.13M	$ -17.64M	$ -19.66M	$ -11.44M	$ -24.64M
Investing Cash Flow	$ -459.79M	$ 35.73M	$ -12.53M	$ -204.48M	$ 2.20M
Financing Cash Flow	$ 606.04M	$ 188.00K	$ -74.00K	$ 267.08M	$ 4.18M

Currency in USD

Viking Therapeutics Earnings and Revenue History

Income Statement >

Viking Therapeutics Debt to Assets

Balance Sheet >

Viking Therapeutics Cash Flow

Cash Flow >

Viking Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing